RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
 Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Research Article
Latest Research Channel

subscribe to Latest Research newsletter
Latest Research

   EMAIL   |   PRINT
AACR Annual Meeting showcases significant developments in understanding and targeting cancers

Apr 10, 2007 - 4:00:00 AM
AACR’s Annual Meeting attracts attendees including leading academic, industry and government scientists, as well as clinical oncologists, students, cancer survivors, advocates and other health care professionals. Such a diverse group facilitates a cross-disciplinary exchange of new ideas and collaborations. This year, more than 6,000 abstracts were submitted for presentation, complementing an outstanding program of scientific and educational events.

 
[RxPG] LOS ANGELES -- Data demonstrating genetic differences in individuals’ susceptibility to certain cancers as well as differences in how people respond to specific cancer treatments will take center stage when more than 17,000 scientists from around the world gather at the Los Angeles Convention Center April 14-18 for the 2007 Annual Meeting of the American Association for Cancer Research (AACR). Key data presented at the meeting will also include findings related to the safety and effectiveness of several new, high-profile cancer therapies and vaccines.

Because of significant diagnostic and therapeutic advances such as personalized and targeted therapies that prolong patients’ lives, the number of people successfully managing and living with cancer continues to grow, said Geoffrey M. Wahl, Ph.D., President, AACR. By hosting the largest meeting in the world of its kind – where the science behind these significant developments is shared and analyzed by researchers at the leading edge of cancer study – the AACR promotes clinical exchange with the goal of ensuring research discoveries translate directly into improved patient outcomes.

The theme of this year’s annual meeting, A Century of Leadership in Science – A Future of Cancer Prevention and Cures, commemorates the AACR’s Centennial and underscores the remarkable scientific advances that researchers have achieved in the 100 years since the organization’s founding, well as the critical importance of ongoing research.

The opening Centennial Ceremony will set an exciting and inspirational tone for a week of science and discovery, with a procession of young researchers bearing flags of all 70 AACR member nations, appearances by the University of Southern California (USC) Marching Band, the All-American Boys’ Choir and presentation of Centennial Medals and other honors to leading cancer researchers and advocates.

The opening plenary, Translating a Century of Science into a Future of Cancer Prevention and Cures – featuring world leaders in the fields of cancer genetics, cellular metabolism, stem cell biology, molecular diagnostics, targeted therapies, early detection and the impact of future cancer science on public health – will provide a vantage point for historical and current perspectives across the spectrum of basic and applied cancer science.Late-breaking plenary sessions in basic, translational and clinical cancer research will cover the latest advances from the laboratory and their translational potential to the clinic. Special sessions will also feature phase I and phase II studies of novel therapeutic agents in early-stage clinical trials, as well as the latest phase III clinical trial findings.

This meeting provides an unmatched opportunity to exchange information on current and emerging discoveries, forge new collaborations and identify future opportunities in virtually all areas of modern cancer research and patient care, said Ronald A. DePinho, M.D., scientific chairperson of the 2007 AACR Program Committee. In our Centennial year, this deeply reflects the intent of our founders on a scale that they could scarcely imagine.

AACR’s Annual Meeting attracts attendees including leading academic, industry and government scientists, as well as clinical oncologists, students, cancer survivors, advocates and other health care professionals. Such a diverse group facilitates a cross-disciplinary exchange of new ideas and collaborations. This year, more than 6,000 abstracts were submitted for presentation, complementing an outstanding program of scientific and educational events.

Among meeting highlights, the AACR has selected more than 35 scientific abstracts for presentation by their authors in 10 press briefings, each highlighting a critical or emerging area of cancer research. Featured press briefing topics include:




Advertise in this space for $10 per month. Contact us today.


Related Latest Research News


Subscribe to Latest Research Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)